Showing results (21-30 of 1,208) with videos related to
Sort By:
Pageof 121
The EMBO Journal|June 23, 2021
TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cellsJana Koch, Zina M Uckeley, Patricio Doldan, et al.Cell Host & Microbe|July 20, 2011
DC-SIGN as a receptor for phlebovirusesPierre-Yves Lozach, Andreas Kühbacher, Roger Meier, et al.Journal of Virology|August 23, 2013
Role of DC-SIGN in Lassa virus entry into human dendritic cellsAna-Rita Goncalves, Marie-Laurence Moraz, Antonella Pasquato, et al.Journal of Virology|May 20, 2016
Uukuniemi Virus as a Tick-Borne Virus ModelMagalie Mazelier, Ronan Nicolas Rouxel, Michael Zumstein, et al.Traffic (Copenhagen, Denmark)|March 19, 2016
Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus EndocytosisPsylvia Léger, Marilou Tetard, Berthe Youness, et al.Chemistry of Materials : a Publication of the American Chemical Society|June 5, 2013
Hybrid, silica-coated, Janus-like plasmonic-magnetic nanoparticlesGeorgios A Sotiriou, Ann M Hirt, Pierre-Yves Lozach, et al.Journal of Virological Methods|June 29, 2013
A rapid method for infectivity titration of Andes hantavirus using flow cytometryGonzalo P Barriga, Constanza Martínez-Valdebenito, Héctor Galeno, et al.Journal of Molecular Biology|November 21, 2002
DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agentsV R de Soultrait, Pierre Yves Lozach, Ralf Altmeyer, et al.Viruses|September 11, 2019
NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In VivoShufen Li, Xiangtao Zhu, Zhenqiong Guan, et al.Virulence|April 3, 2026
Pathogenicity of Rift valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative reviewFiona Nicole, Anne-Flore Legrand, Marie-Pierre Confort, et al.Pageof 121